Ciputra Development Tbk vs Kalbe Farma Tbk — how do they compare? Ciputra Development Tbk trades at Rp560 (market cap 10.29T, 11.27M 24h volume), while Kalbe Farma Tbk trades at Rp705 (market cap 34.17T, 156.61M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 3.3× Ciputra Development Tbk's market cap, and Kalbe Farma Tbk is more actively traded (156.61M versus 11.27M). Which is the better fit depends on your goals.
| CTRA | KLBF | |
|---|---|---|
Market Cap | 10.29T | 34.17T |
Volume | 11.27M | 156.61M |
Lot | 112.75K | 1.57M |
Turnover | 6.32B | 111.23B |
Average Price | 560.45 | 710.21 |
Value | 6.32B | 111.23B |
Indicative Equilibrium Price | 560 | 705 |
Indicative Equilibrium Volume | 3.05K | 56.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →